Arcturus Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $28,301 | $29,382 | $21,000 | $38,815 |
Gross Profit | 29,382 | 21,000 | 2,539 | |
EBITDA | -11,616 | -16,025 | -17,851 | -9,825 |
EBIT | -16,826 | -18,670 | -10,737 | |
Net Income | -9,180 | -14,076 | -30,005 | -6,903 |
Net Change In Cash | 28,301 | 29,382 | 21,000 | 38,815 |
Free Cash Flow | -5,755 | -35,138 | -284 | -23,493 |
Cash | 196,467 | 216,948 | 237,028 | 237,178 |
Basic Shares | 27,129 | 27,107 | 27,000 | 27,062 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $138,389 | $157,748 | $205,755 | $12,359 |
Gross Profit | 134,845 | 154,791 | 58,248 | -161,401 |
EBITDA | -77,401 | -24,166 | 13,704 | -201,659 |
EBIT | -80,945 | -27,123 | 12,177 | -202,852 |
Net Income | -80,941 | -29,725 | 9,349 | -203,674 |
Net Change In Cash | 138,389 | 157,748 | 205,755 | 12,359 |
Cost of Revenue | -90,433 | |||
Free Cash Flow | -60,395 | -21,000 | 24,267 | -138,449 |
Cash | 237,028 | 292,005 | 391,883 | 370,492 |
Basic Shares | 27,000 | 26,628 | 27,093 | 26,317 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.34 |
2025-03-31 | -$0.52 |
2024-12-31 | -$1.11 |
